- ExactTarget Names New Board Member
- Businessweek Picks 'Best Place to Raise Kids' in Indiana
- Crossroads Radio Announces New GM
- Jobless Benefits to be Extended
- Renovation Plans For South Bend Stadium Move Forward
- CSX Unveils Low-Emission Locomotives
- Airport Lands Monumental Award
- Community Breast Care Accredited
- [UPDATED] Purdue to Cut $30 Million
updated: 7/17/2008 11:22:57 AM
Merck Funds HPV Research at Kelley School
Pharmaceutical manufacturer Merck and Co. (NYSE:MRK) has awarded two Indiana University Kelley School of Business professors a $79,000 research grant to study the effect of two interventions on acceptance of the HPV (human papillomavirus) vaccination among low-income and minority women. HPV is the virus that causes cervical cancer. Professor Dena Cox will focus on how consumers make health care decisions and co-investigator, professor Anthony Cox, will study how consumers evaluate risk in making medical treatment decisions.
Source: Inside INdiana Business
 Jeff Patchen, President and CEO, The Children's Museum of IndianapolisIn a Studio(i) interview, The Children's Museum of Indianapolis Presiden... |
 Jerry Conover, Director, Indiana Business Research CenterIn a Studio(i) interview, IBRC Director Jerry Conover talked about both ... |
 Matt Gutwein, CEO, Marion County Health and Hospital Corp.In a Studio(i) interview, Gutwein discusses the Wishard project with Ins... |
FrontPg.jpg)
Press Release
INDIANAPOLIS, July 17, 2008 – Two Kelley School of Business Indianapolis professors were recently awarded a $79,000 research grant by pharmaceutical giant Merck and Company. The co-investigators, Eli Lilly Fellow Dena Cox and Chancellor’s Fellow Anthony D. Cox, both professors of marketing at the Kelley School of Business Indianapolis, will conduct a two-year study examining the effect of two interventions on acceptance of the HPV (human papillomavirus) vaccination among low-income and minority women. HPV is the virus that causes cervical cancer.
Dena Cox, the principal investigator on the study, had a previous career as a microbiologist before receiving a Ph.D. in marketing from the University of Houston. Her research focuses on how consumers make health care decisions. Co-investigator Anthony Cox, who earned his Ph.D. in marketing from Indiana University, studies how consumers evaluate risk in making medical treatment decisions. Their collaborative research has been funded by numerous external grants, and has appeared in top journals in both business and medicine.
HPV is a sexually-transmitted virus that plays a key role in the development of cervical cancer. HPV vaccination of young women and girls has been shown to reduce their lifetime risk of cervical cancer by as much as 70%. The HPV vaccine is expected to be an especially important tool in reducing cervical cancer among low income and minority women, since these women are often less likely to receive regular cervical cancer screening. Thus, the research will seek the most effective ways to present HPV vaccine risk and benefit information to low-income Hispanic, African-American and White women, so that they can make informed HPV vaccination decisions.
About Kelley School of Business at Indianapolis
The IU Kelley School of Business has been a leader in American business education for more than 80 years. With an enrollment of more than 4,800 undergraduate and nearly 2,000 graduate students, it is among the premier business schools in the country. Kelley’s Indianapolis campus, based at IUPUI, is home to the school’s Evening MBA and Master of Science in Accounting programs and a full-time undergraduate program.
Source: IU Kelley School of Business
